Chartwell Investment Partners, LLC Gilead Sciences, Inc. Transaction History

Chartwell Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $2.78 Million - $3.08 Million	-39,000 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $1.25 Million - $1.46 Million	-19,300 Reduced 33.1%	39,000 $2.76 Million
Q1 2018 May 08, 2018	BUY	$72.84 - $88.8 $1.38 Million - $1.69 Million	19,000 Added 48.35%	58,300 $4.18 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $1.38 Million - $1.69 Million	-19,000 Reduced 32.59%	39,300 $2.96 Million
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $64,035 - $75,168	-900 Reduced 1.52%	58,300 $4.18 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $4.27 Million - $5.06 Million	59,200	59,200 $4.8 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.